100% Response Rate Achieved with All Doses of RDEA594 Combined with Febuxostat or Allopurinol; Serum Uric Acid Levels Reduced by Up to 80% SAN DIEGO, Nov. 8, 2010 ...

Febuxostat 40 mg daily appears to be as efficacious as allopurinol in lowering serum uric acid levels. [38] Both febuxostat 40 and 80 mg can be given to patients with mild-to-moderate renal impairment ...

Trial subgroup analyses support the use of either allopurinol or febuxostat in patients with stage 3 CKD and gout. A prespecified analysis of the STOP-GOUT trial revealed that allopurinol has similar ...

Results from this study demonstrated patients with early gout treated with febuxostat had improvements in MRI synovitis and a decrease in gout flares compared with patients in a placebo group. Dalbeth ...

Please provide your email address to receive an email when new articles are posted on . Lesinurad, a selective uric acid reabsorption inhibitor, in combination with febuxostat may help reduce tophi ...

In contrast to CARES, FAST found that treatment with febuxostat was not associated with an increase in cardiovascular or all-cause death compared with allopurinol in patients with gout. Febuxostat ...

First new treatment option in more than 40 years, marking second FDA approval for Takeda within one month DEERFIELD, Ill., and OSAKA, Japan, Feb. 13 /PRNewswire/ -- Takeda Pharmaceutical Company ...

Review the side-effects of Febuxostat as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. The information provided on this page is intended ...

The efficacy and safety of febuxostat was noninferior to allopurinol for preventing tumor lysis syndrome (TLS) in patients with malignant tumors about to receive chemotherapy, according to a new study ...

February 17, 2009 — The US Food and Drug Administration (FDA) last week approved febuxostat (Uloric), 40 mg and 80 mg, administered orally once daily, for chronic management of hyperuricemia in ...